University of Rochester Medical Center researchers have found a way to selectively block the ability of white blood cells to “crawl” toward the sites of injury and infection when such mobility drives disease.

The results suggest a new treatment approach for autoimmune diseases and conditions made worse by inflammation such as atherosclerosis and stroke.